Causal effect of plasminogen activator inhibitor type 1 on coronary heart disease.
Journal of the American Heart Association.
Times cited: 34
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.
Times cited: 106
Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: Individual participant meta-analysis.
International Journal of Epidemiology.
Times cited: 138